Skip to search.
 TSX Up 2.43% TSX Ventures Up 0.55%

Merck & Co. Inc. (MRK)

-NYSE
49.03 Up 0.18(0.37%) Feb 12, 4:01PM EST
|After Hours : 49.00 Down 0.03 (0.06%) Feb 12, 7:55PM EST
Prev Close:48.85
Open:48.98
Bid:48.89 x 200
Ask:49.05 x 200
1y Target Est:60.95
Beta:0.748345
Next Earnings Date: 5-May-16MRK Earnings announcement
Day's Range:48.28 - 49.11
52wk Range:45.69 - 61.70
Volume:13,598,265
Avg Vol (3m):11,593,800
Market Cap:136.97B
P/E (ttm):31.43
EPS (ttm):1.56
Div & Yield:1.84 (3.77%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MRKUp 0.37%136.97B
GSKUp 1.56%96.22B
PFEUp 0.79%181.25B

Key Statistics

Forward P/E (1 yr):12.87
P/S (ttm):3.45
Ex-Dividend Date:11-Dec-15

Analysts

Annual EPS Est (Dec-16) :3.71
Quarterly EPS Est (Mar-16) :0.85
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):3.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback